nodes	percent_of_prediction	percent_of_DWPC	metapath
Diclofenac—Tongue coated—Varenicline—nicotine dependence	0.0385	0.0698	CcSEcCtD
Diclofenac—Vitreous floaters—Varenicline—nicotine dependence	0.0229	0.0416	CcSEcCtD
Diclofenac—Night blindness—Varenicline—nicotine dependence	0.0221	0.0401	CcSEcCtD
Diclofenac—KCNQ3—cardiovascular system—nicotine dependence	0.0129	0.0751	CbGeAlD
Diclofenac—ASIC1—midbrain—nicotine dependence	0.0126	0.0738	CbGeAlD
Diclofenac—Aphthous stomatitis—Varenicline—nicotine dependence	0.0111	0.0202	CcSEcCtD
Diclofenac—Sinus congestion—Varenicline—nicotine dependence	0.0105	0.019	CcSEcCtD
Diclofenac—KCNQ3—midbrain—nicotine dependence	0.01	0.0587	CbGeAlD
Diclofenac—PLA2G2A—cardiovascular system—nicotine dependence	0.00974	0.0569	CbGeAlD
Diclofenac—TTR—Retinoid metabolism and transport—AKR1B10—nicotine dependence	0.00952	0.0342	CbGpPWpGaD
Diclofenac—CYP2C18—Xenobiotics—CYP2A7—nicotine dependence	0.00902	0.0324	CbGpPWpGaD
Diclofenac—Platelet count decreased—Varenicline—nicotine dependence	0.00875	0.0159	CcSEcCtD
Diclofenac—Toothache—Varenicline—nicotine dependence	0.00856	0.0155	CcSEcCtD
Diclofenac—ASIC1—brain—nicotine dependence	0.00793	0.0464	CbGeAlD
Diclofenac—ASIC1—Ion channel transport—GABRA4—nicotine dependence	0.00787	0.0283	CbGpPWpGaD
Diclofenac—PLA2G2A—midbrain—nicotine dependence	0.00761	0.0445	CbGeAlD
Diclofenac—CXCL8—midbrain—nicotine dependence	0.00753	0.044	CbGeAlD
Diclofenac—Haematemesis—Varenicline—nicotine dependence	0.00749	0.0136	CcSEcCtD
Diclofenac—TTR—cardiovascular system—nicotine dependence	0.00735	0.043	CbGeAlD
Diclofenac—CYP2B6—CYP2E1 reactions—CYP2A7—nicotine dependence	0.00716	0.0257	CbGpPWpGaD
Diclofenac—CYP2E1—CYP2E1 reactions—CYP2A7—nicotine dependence	0.00701	0.0252	CbGpPWpGaD
Diclofenac—Scotoma—Varenicline—nicotine dependence	0.00685	0.0124	CcSEcCtD
Diclofenac—ALOX5—cardiovascular system—nicotine dependence	0.00666	0.039	CbGeAlD
Diclofenac—Gingivitis—Varenicline—nicotine dependence	0.00663	0.012	CcSEcCtD
Diclofenac—SLCO1C1—midbrain—nicotine dependence	0.00642	0.0376	CbGeAlD
Diclofenac—KCNQ3—brain—nicotine dependence	0.00631	0.0369	CbGeAlD
Diclofenac—Acne—Varenicline—nicotine dependence	0.00619	0.0112	CcSEcCtD
Diclofenac—Eye irritation—Varenicline—nicotine dependence	0.0061	0.0111	CcSEcCtD
Diclofenac—CYP2C8—CYP2E1 reactions—CYP2A7—nicotine dependence	0.00606	0.0218	CbGpPWpGaD
Diclofenac—Disturbance in attention—Varenicline—nicotine dependence	0.00601	0.0109	CcSEcCtD
Diclofenac—Accidental injury—Varenicline—nicotine dependence	0.00588	0.0107	CcSEcCtD
Diclofenac—KCNQ2—brain—nicotine dependence	0.0058	0.0339	CbGeAlD
Diclofenac—Viral infection—Varenicline—nicotine dependence	0.00576	0.0105	CcSEcCtD
Diclofenac—Ventricular extrasystoles—Varenicline—nicotine dependence	0.00576	0.0105	CcSEcCtD
Diclofenac—TTR—midbrain—nicotine dependence	0.00574	0.0336	CbGeAlD
Diclofenac—Thinking abnormal—Varenicline—nicotine dependence	0.00569	0.0103	CcSEcCtD
Diclofenac—Lacrimation increased—Varenicline—nicotine dependence	0.00565	0.0103	CcSEcCtD
Diclofenac—Nocturia—Varenicline—nicotine dependence	0.00561	0.0102	CcSEcCtD
Diclofenac—CYP2B6—Fatty acids—CYP2A7—nicotine dependence	0.00558	0.0201	CbGpPWpGaD
Diclofenac—CYP2C19—CYP2E1 reactions—CYP2A7—nicotine dependence	0.00541	0.0194	CbGpPWpGaD
Diclofenac—CXCR1—Peptide GPCRs—OPRM1—nicotine dependence	0.00536	0.0193	CbGpPWpGaD
Diclofenac—Coordination abnormal—Varenicline—nicotine dependence	0.0053	0.00962	CcSEcCtD
Diclofenac—Blood pressure increased—Varenicline—nicotine dependence	0.0052	0.00945	CcSEcCtD
Diclofenac—Eructation—Varenicline—nicotine dependence	0.00511	0.00929	CcSEcCtD
Diclofenac—CXCR1—G alpha (i) signalling events—TAS2R16—nicotine dependence	0.00505	0.0181	CbGpPWpGaD
Diclofenac—Nightmare—Varenicline—nicotine dependence	0.00503	0.00913	CcSEcCtD
Diclofenac—CYP2C9—CYP2E1 reactions—CYP2A7—nicotine dependence	0.00493	0.0177	CbGpPWpGaD
Diclofenac—TTR—Diseases associated with visual transduction—AKR1B10—nicotine dependence	0.00486	0.0175	CbGpPWpGaD
Diclofenac—PLA2G2A—brain—nicotine dependence	0.00478	0.0279	CbGeAlD
Diclofenac—Oesophagitis—Varenicline—nicotine dependence	0.00476	0.00864	CcSEcCtD
Diclofenac—CXCL8—brain—nicotine dependence	0.00473	0.0277	CbGeAlD
Diclofenac—Urine output increased—Varenicline—nicotine dependence	0.00471	0.00854	CcSEcCtD
Diclofenac—Mouth ulceration—Varenicline—nicotine dependence	0.00471	0.00854	CcSEcCtD
Diclofenac—Hypertonia—Varenicline—nicotine dependence	0.00456	0.00828	CcSEcCtD
Diclofenac—Mental disability—Varenicline—nicotine dependence	0.00452	0.0082	CcSEcCtD
Diclofenac—CYP2B6—Xenobiotics—CYP2A7—nicotine dependence	0.00444	0.0159	CbGpPWpGaD
Diclofenac—Lymphadenopathy—Varenicline—nicotine dependence	0.00443	0.00804	CcSEcCtD
Diclofenac—Sleep disorder—Varenicline—nicotine dependence	0.00436	0.00792	CcSEcCtD
Diclofenac—CYP2E1—Xenobiotics—CYP2A7—nicotine dependence	0.00434	0.0156	CbGpPWpGaD
Diclofenac—Polyuria—Varenicline—nicotine dependence	0.0043	0.00781	CcSEcCtD
Diclofenac—Disorientation—Varenicline—nicotine dependence	0.00422	0.00767	CcSEcCtD
Diclofenac—Deafness—Varenicline—nicotine dependence	0.00422	0.00767	CcSEcCtD
Diclofenac—Eczema—Varenicline—nicotine dependence	0.0042	0.00763	CcSEcCtD
Diclofenac—Eye pain—Varenicline—nicotine dependence	0.00418	0.0076	CcSEcCtD
Diclofenac—Injury—Varenicline—nicotine dependence	0.00411	0.00746	CcSEcCtD
Diclofenac—CYP1A1—Xenobiotics—CYP2A7—nicotine dependence	0.0041	0.0147	CbGpPWpGaD
Diclofenac—Renal failure acute—Varenicline—nicotine dependence	0.00409	0.00743	CcSEcCtD
Diclofenac—SLCO1C1—brain—nicotine dependence	0.00404	0.0236	CbGeAlD
Diclofenac—Visual disturbance—Varenicline—nicotine dependence	0.00399	0.00724	CcSEcCtD
Diclofenac—Thirst—Varenicline—nicotine dependence	0.00397	0.00721	CcSEcCtD
Diclofenac—Arthritis—Varenicline—nicotine dependence	0.00389	0.00706	CcSEcCtD
Diclofenac—Hypoglycaemia—Varenicline—nicotine dependence	0.00387	0.00703	CcSEcCtD
Diclofenac—Lethargy—Varenicline—nicotine dependence	0.00386	0.007	CcSEcCtD
Diclofenac—Cerebrovascular accident—Varenicline—nicotine dependence	0.00386	0.007	CcSEcCtD
Diclofenac—Gastrointestinal haemorrhage—Varenicline—nicotine dependence	0.00378	0.00686	CcSEcCtD
Diclofenac—Osteoarthritis—Varenicline—nicotine dependence	0.00378	0.00686	CcSEcCtD
Diclofenac—CYP2C8—Xenobiotics—CYP2A7—nicotine dependence	0.00376	0.0135	CbGpPWpGaD
Diclofenac—CYP2C18—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00375	0.0135	CbGpPWpGaD
Diclofenac—Migraine—Varenicline—nicotine dependence	0.00372	0.00675	CcSEcCtD
Diclofenac—SCN4A—brain—nicotine dependence	0.00371	0.0217	CbGeAlD
Diclofenac—CYP2C18—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.0037	0.0133	CbGpPWpGaD
Diclofenac—SLC22A6—brain—nicotine dependence	0.00369	0.0216	CbGeAlD
Diclofenac—Psychotic disorder—Varenicline—nicotine dependence	0.00369	0.0067	CcSEcCtD
Diclofenac—TTR—brain—nicotine dependence	0.00361	0.0211	CbGeAlD
Diclofenac—Irritability—Varenicline—nicotine dependence	0.00361	0.00655	CcSEcCtD
Diclofenac—Dry skin—Varenicline—nicotine dependence	0.00346	0.00629	CcSEcCtD
Diclofenac—Abdominal pain upper—Varenicline—nicotine dependence	0.00345	0.00627	CcSEcCtD
Diclofenac—KCNQ3—Neuronal System—CHRNB3—nicotine dependence	0.00341	0.0123	CbGpPWpGaD
Diclofenac—KCNQ2—Neuronal System—CHRNB3—nicotine dependence	0.00341	0.0123	CbGpPWpGaD
Diclofenac—Cramp muscle—Varenicline—nicotine dependence	0.0034	0.00618	CcSEcCtD
Diclofenac—Nasopharyngitis—Varenicline—nicotine dependence	0.00338	0.00613	CcSEcCtD
Diclofenac—CYP2C19—Xenobiotics—CYP2A7—nicotine dependence	0.00335	0.012	CbGpPWpGaD
Diclofenac—Gastritis—Varenicline—nicotine dependence	0.00334	0.00607	CcSEcCtD
Diclofenac—Abdominal distension—Varenicline—nicotine dependence	0.00329	0.00597	CcSEcCtD
Diclofenac—ALOX5—brain—nicotine dependence	0.00327	0.0191	CbGeAlD
Diclofenac—Asthma—Varenicline—nicotine dependence	0.00327	0.00593	CcSEcCtD
Diclofenac—KCNQ3—Neuronal System—CHRNA6—nicotine dependence	0.00324	0.0116	CbGpPWpGaD
Diclofenac—KCNQ2—Neuronal System—CHRNA6—nicotine dependence	0.00324	0.0116	CbGpPWpGaD
Diclofenac—Angina pectoris—Varenicline—nicotine dependence	0.00318	0.00578	CcSEcCtD
Diclofenac—Bronchitis—Varenicline—nicotine dependence	0.00314	0.0057	CcSEcCtD
Diclofenac—Abdominal discomfort—Varenicline—nicotine dependence	0.00313	0.00568	CcSEcCtD
Diclofenac—CYP2C9—Xenobiotics—CYP2A7—nicotine dependence	0.00306	0.011	CbGpPWpGaD
Diclofenac—CXCR1—GPCR ligand binding—TAS2R16—nicotine dependence	0.00306	0.011	CbGpPWpGaD
Diclofenac—CYP2C18—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00304	0.0109	CbGpPWpGaD
Diclofenac—Pollakiuria—Varenicline—nicotine dependence	0.00302	0.00548	CcSEcCtD
Diclofenac—Erectile dysfunction—Varenicline—nicotine dependence	0.00301	0.00546	CcSEcCtD
Diclofenac—Photosensitivity reaction—Varenicline—nicotine dependence	0.00298	0.00541	CcSEcCtD
Diclofenac—Weight increased—Varenicline—nicotine dependence	0.00297	0.0054	CcSEcCtD
Diclofenac—CYP2B6—cardiovascular system—nicotine dependence	0.00296	0.0173	CbGeAlD
Diclofenac—Hyperglycaemia—Varenicline—nicotine dependence	0.00295	0.00535	CcSEcCtD
Diclofenac—CYP2C9—cardiovascular system—nicotine dependence	0.00293	0.0171	CbGeAlD
Diclofenac—Infestation NOS—Varenicline—nicotine dependence	0.00291	0.00529	CcSEcCtD
Diclofenac—Infestation—Varenicline—nicotine dependence	0.00291	0.00529	CcSEcCtD
Diclofenac—Depression—Varenicline—nicotine dependence	0.0029	0.00527	CcSEcCtD
Diclofenac—Stevens-Johnson syndrome—Varenicline—nicotine dependence	0.00289	0.00524	CcSEcCtD
Diclofenac—Acute coronary syndrome—Varenicline—nicotine dependence	0.00287	0.00521	CcSEcCtD
Diclofenac—Myocardial infarction—Varenicline—nicotine dependence	0.00285	0.00518	CcSEcCtD
Diclofenac—Stomatitis—Varenicline—nicotine dependence	0.00284	0.00515	CcSEcCtD
Diclofenac—Conjunctivitis—Varenicline—nicotine dependence	0.00283	0.00514	CcSEcCtD
Diclofenac—CYP2E1—cardiovascular system—nicotine dependence	0.00278	0.0162	CbGeAlD
Diclofenac—Hepatobiliary disease—Varenicline—nicotine dependence	0.00275	0.005	CcSEcCtD
Diclofenac—Epistaxis—Varenicline—nicotine dependence	0.00275	0.00499	CcSEcCtD
Diclofenac—ASIC1—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.00274	0.00985	CbGpPWpGaD
Diclofenac—Sinusitis—Varenicline—nicotine dependence	0.00273	0.00496	CcSEcCtD
Diclofenac—PTGS1—cardiovascular system—nicotine dependence	0.00268	0.0156	CbGeAlD
Diclofenac—Bradycardia—Varenicline—nicotine dependence	0.00266	0.00483	CcSEcCtD
Diclofenac—CYP1A2—Xenobiotics—CYP2A7—nicotine dependence	0.00261	0.00939	CbGpPWpGaD
Diclofenac—Hypoaesthesia—Varenicline—nicotine dependence	0.0026	0.00472	CcSEcCtD
Diclofenac—Hallucination—Varenicline—nicotine dependence	0.0026	0.00472	CcSEcCtD
Diclofenac—Urinary tract disorder—Varenicline—nicotine dependence	0.00258	0.00469	CcSEcCtD
Diclofenac—Oedema peripheral—Varenicline—nicotine dependence	0.00257	0.00468	CcSEcCtD
Diclofenac—Urethral disorder—Varenicline—nicotine dependence	0.00256	0.00465	CcSEcCtD
Diclofenac—PTGS2—cardiovascular system—nicotine dependence	0.00256	0.0149	CbGeAlD
Diclofenac—CXCR1—Peptide ligand-binding receptors—OPRM1—nicotine dependence	0.00252	0.00907	CbGpPWpGaD
Diclofenac—Visual impairment—Varenicline—nicotine dependence	0.00252	0.00457	CcSEcCtD
Diclofenac—Erythema multiforme—Varenicline—nicotine dependence	0.00247	0.00449	CcSEcCtD
Diclofenac—Eye disorder—Varenicline—nicotine dependence	0.00244	0.00444	CcSEcCtD
Diclofenac—Tinnitus—Varenicline—nicotine dependence	0.00244	0.00442	CcSEcCtD
Diclofenac—Cardiac disorder—Varenicline—nicotine dependence	0.00243	0.0044	CcSEcCtD
Diclofenac—Angiopathy—Varenicline—nicotine dependence	0.00237	0.00431	CcSEcCtD
Diclofenac—Immune system disorder—Varenicline—nicotine dependence	0.00236	0.00429	CcSEcCtD
Diclofenac—Mediastinal disorder—Varenicline—nicotine dependence	0.00236	0.00428	CcSEcCtD
Diclofenac—Chills—Varenicline—nicotine dependence	0.00235	0.00426	CcSEcCtD
Diclofenac—KCNQ2—Neuronal System—GABRA4—nicotine dependence	0.00234	0.00841	CbGpPWpGaD
Diclofenac—KCNQ3—Neuronal System—GABRA4—nicotine dependence	0.00234	0.00841	CbGpPWpGaD
Diclofenac—Arrhythmia—Varenicline—nicotine dependence	0.00233	0.00424	CcSEcCtD
Diclofenac—ALB—brain—nicotine dependence	0.0023	0.0135	CbGeAlD
Diclofenac—Mental disorder—Varenicline—nicotine dependence	0.00229	0.00416	CcSEcCtD
Diclofenac—CXCL8—G alpha (i) signalling events—TAS2R16—nicotine dependence	0.00228	0.00819	CbGpPWpGaD
Diclofenac—Erythema—Varenicline—nicotine dependence	0.00228	0.00413	CcSEcCtD
Diclofenac—Malnutrition—Varenicline—nicotine dependence	0.00228	0.00413	CcSEcCtD
Diclofenac—KCNQ3—Neuronal System—CHRNB4—nicotine dependence	0.00224	0.00806	CbGpPWpGaD
Diclofenac—KCNQ2—Neuronal System—CHRNB4—nicotine dependence	0.00224	0.00806	CbGpPWpGaD
Diclofenac—Flatulence—Varenicline—nicotine dependence	0.00224	0.00407	CcSEcCtD
Diclofenac—ABCC4—brain—nicotine dependence	0.00223	0.013	CbGeAlD
Diclofenac—Dysgeusia—Varenicline—nicotine dependence	0.00223	0.00405	CcSEcCtD
Diclofenac—SLC22A8—brain—nicotine dependence	0.00221	0.0129	CbGeAlD
Diclofenac—Back pain—Varenicline—nicotine dependence	0.0022	0.004	CcSEcCtD
Diclofenac—Muscle spasms—Varenicline—nicotine dependence	0.00219	0.00397	CcSEcCtD
Diclofenac—Vision blurred—Varenicline—nicotine dependence	0.00214	0.00389	CcSEcCtD
Diclofenac—Tremor—Varenicline—nicotine dependence	0.00213	0.00387	CcSEcCtD
Diclofenac—CXCR1—G alpha (i) signalling events—OPRM1—nicotine dependence	0.00213	0.00765	CbGpPWpGaD
Diclofenac—Ill-defined disorder—Varenicline—nicotine dependence	0.00211	0.00383	CcSEcCtD
Diclofenac—Anaemia—Varenicline—nicotine dependence	0.0021	0.00382	CcSEcCtD
Diclofenac—Agitation—Varenicline—nicotine dependence	0.00209	0.0038	CcSEcCtD
Diclofenac—KCNQ2—Neuronal System—CHRNA5—nicotine dependence	0.00209	0.0075	CbGpPWpGaD
Diclofenac—KCNQ3—Neuronal System—CHRNA5—nicotine dependence	0.00209	0.0075	CbGpPWpGaD
Diclofenac—Angioedema—Varenicline—nicotine dependence	0.00208	0.00377	CcSEcCtD
Diclofenac—Malaise—Varenicline—nicotine dependence	0.00205	0.00373	CcSEcCtD
Diclofenac—Vertigo—Varenicline—nicotine dependence	0.00204	0.00371	CcSEcCtD
Diclofenac—Syncope—Varenicline—nicotine dependence	0.00204	0.0037	CcSEcCtD
Diclofenac—CYP3A4—Xenobiotics—CYP2A7—nicotine dependence	0.00202	0.00725	CbGpPWpGaD
Diclofenac—Palpitations—Varenicline—nicotine dependence	0.00201	0.00365	CcSEcCtD
Diclofenac—Loss of consciousness—Varenicline—nicotine dependence	0.002	0.00363	CcSEcCtD
Diclofenac—PTGS2—midbrain—nicotine dependence	0.002	0.0117	CbGeAlD
Diclofenac—Cough—Varenicline—nicotine dependence	0.00199	0.00361	CcSEcCtD
Diclofenac—CXCR1—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.00197	0.0071	CbGpPWpGaD
Diclofenac—Convulsion—Varenicline—nicotine dependence	0.00197	0.00358	CcSEcCtD
Diclofenac—Hypertension—Varenicline—nicotine dependence	0.00196	0.00357	CcSEcCtD
Diclofenac—PTGS1—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00196	0.00704	CbGpPWpGaD
Diclofenac—CXCL8—SIDS Susceptibility Pathways—CHRNB4—nicotine dependence	0.00195	0.00702	CbGpPWpGaD
Diclofenac—Arthralgia—Varenicline—nicotine dependence	0.00194	0.00352	CcSEcCtD
Diclofenac—Chest pain—Varenicline—nicotine dependence	0.00194	0.00352	CcSEcCtD
Diclofenac—Myalgia—Varenicline—nicotine dependence	0.00194	0.00352	CcSEcCtD
Diclofenac—Anxiety—Varenicline—nicotine dependence	0.00193	0.00351	CcSEcCtD
Diclofenac—Unspecified disorder of skin and subcutaneous tissue—Varenicline—nicotine dependence	0.00192	0.00349	CcSEcCtD
Diclofenac—Discomfort—Varenicline—nicotine dependence	0.00191	0.00348	CcSEcCtD
Diclofenac—ABCC1—brain—nicotine dependence	0.0019	0.0111	CbGeAlD
Diclofenac—Dry mouth—Varenicline—nicotine dependence	0.00189	0.00344	CcSEcCtD
Diclofenac—Oedema—Varenicline—nicotine dependence	0.00186	0.00337	CcSEcCtD
Diclofenac—Infection—Varenicline—nicotine dependence	0.00184	0.00335	CcSEcCtD
Diclofenac—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00184	0.00662	CbGpPWpGaD
Diclofenac—Shock—Varenicline—nicotine dependence	0.00183	0.00332	CcSEcCtD
Diclofenac—Nervous system disorder—Varenicline—nicotine dependence	0.00182	0.00331	CcSEcCtD
Diclofenac—Thrombocytopenia—Varenicline—nicotine dependence	0.00182	0.0033	CcSEcCtD
Diclofenac—CYP2B6—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00182	0.00653	CbGpPWpGaD
Diclofenac—Tachycardia—Varenicline—nicotine dependence	0.00181	0.00329	CcSEcCtD
Diclofenac—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.0018	0.00649	CbGpPWpGaD
Diclofenac—Skin disorder—Varenicline—nicotine dependence	0.0018	0.00328	CcSEcCtD
Diclofenac—Hyperhidrosis—Varenicline—nicotine dependence	0.0018	0.00326	CcSEcCtD
Diclofenac—CYP2E1—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00178	0.0064	CbGpPWpGaD
Diclofenac—Anorexia—Varenicline—nicotine dependence	0.00177	0.00321	CcSEcCtD
Diclofenac—Hypotension—Varenicline—nicotine dependence	0.00174	0.00315	CcSEcCtD
Diclofenac—CXCR1—GPCR downstream signaling—TAS2R16—nicotine dependence	0.00173	0.00621	CbGpPWpGaD
Diclofenac—CYP2C18—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00171	0.00615	CbGpPWpGaD
Diclofenac—CYP1A1—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.0017	0.00611	CbGpPWpGaD
Diclofenac—KCNQ3—Neuronal System—CHRNA3—nicotine dependence	0.0017	0.00611	CbGpPWpGaD
Diclofenac—KCNQ2—Neuronal System—CHRNA3—nicotine dependence	0.0017	0.00611	CbGpPWpGaD
Diclofenac—Musculoskeletal discomfort—Varenicline—nicotine dependence	0.00169	0.00307	CcSEcCtD
Diclofenac—CXCR1—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.00169	0.00608	CbGpPWpGaD
Diclofenac—Insomnia—Varenicline—nicotine dependence	0.00168	0.00305	CcSEcCtD
Diclofenac—CYP1A1—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00168	0.00603	CbGpPWpGaD
Diclofenac—UGT2B7—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00166	0.00599	CbGpPWpGaD
Diclofenac—Dyspnoea—Varenicline—nicotine dependence	0.00166	0.00301	CcSEcCtD
Diclofenac—Somnolence—Varenicline—nicotine dependence	0.00165	0.003	CcSEcCtD
Diclofenac—Dyspepsia—Varenicline—nicotine dependence	0.00163	0.00297	CcSEcCtD
Diclofenac—CYP2C8—brain—nicotine dependence	0.00162	0.00946	CbGeAlD
Diclofenac—Decreased appetite—Varenicline—nicotine dependence	0.00161	0.00293	CcSEcCtD
Diclofenac—CYP2C18—Biological oxidations—CYP2A7—nicotine dependence	0.00161	0.0058	CbGpPWpGaD
Diclofenac—Gastrointestinal disorder—Varenicline—nicotine dependence	0.0016	0.00291	CcSEcCtD
Diclofenac—Fatigue—Varenicline—nicotine dependence	0.0016	0.00291	CcSEcCtD
Diclofenac—CYP2C18—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00159	0.00572	CbGpPWpGaD
Diclofenac—Constipation—Varenicline—nicotine dependence	0.00159	0.00288	CcSEcCtD
Diclofenac—Pain—Varenicline—nicotine dependence	0.00159	0.00288	CcSEcCtD
Diclofenac—ABCB1—cardiovascular system—nicotine dependence	0.00158	0.00924	CbGeAlD
Diclofenac—UGT2B7—Biological oxidations—CYP2A7—nicotine dependence	0.00157	0.00564	CbGpPWpGaD
Diclofenac—CXCR1—Signaling by GPCR—TAS2R16—nicotine dependence	0.00157	0.00564	CbGpPWpGaD
Diclofenac—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00156	0.00561	CbGpPWpGaD
Diclofenac—UGT2B7—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00155	0.00556	CbGpPWpGaD
Diclofenac—CYP2C8—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00154	0.00553	CbGpPWpGaD
Diclofenac—CXCR1—G alpha (i) signalling events—DRD2—nicotine dependence	0.00154	0.00553	CbGpPWpGaD
Diclofenac—Feeling abnormal—Varenicline—nicotine dependence	0.00153	0.00278	CcSEcCtD
Diclofenac—Gastrointestinal pain—Varenicline—nicotine dependence	0.00152	0.00276	CcSEcCtD
Diclofenac—KCNQ2—Neuronal System—CHRNB2—nicotine dependence	0.0015	0.00538	CbGpPWpGaD
Diclofenac—KCNQ3—Neuronal System—CHRNB2—nicotine dependence	0.0015	0.00538	CbGpPWpGaD
Diclofenac—CYP1A1—brain—nicotine dependence	0.00149	0.00873	CbGeAlD
Diclofenac—CYP2B6—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00149	0.00537	CbGpPWpGaD
Diclofenac—Urticaria—Varenicline—nicotine dependence	0.00148	0.00268	CcSEcCtD
Diclofenac—Abdominal pain—Varenicline—nicotine dependence	0.00147	0.00267	CcSEcCtD
Diclofenac—Body temperature increased—Varenicline—nicotine dependence	0.00147	0.00267	CcSEcCtD
Diclofenac—CYP2E1—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00146	0.00526	CbGpPWpGaD
Diclofenac—CYP2B6—brain—nicotine dependence	0.00145	0.00849	CbGeAlD
Diclofenac—CXCR1—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.00143	0.00513	CbGpPWpGaD
Diclofenac—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00139	0.005	CbGpPWpGaD
Diclofenac—CXCL8—GPCR ligand binding—TAS2R16—nicotine dependence	0.00138	0.00496	CbGpPWpGaD
Diclofenac—CYP1A1—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00138	0.00496	CbGpPWpGaD
Diclofenac—CYP2C19—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00137	0.00494	CbGpPWpGaD
Diclofenac—Hypersensitivity—Varenicline—nicotine dependence	0.00137	0.00248	CcSEcCtD
Diclofenac—CYP2E1—brain—nicotine dependence	0.00136	0.00796	CbGeAlD
Diclofenac—KCNQ3—Neuronal System—CHRNA4—nicotine dependence	0.00136	0.00489	CbGpPWpGaD
Diclofenac—KCNQ2—Neuronal System—CHRNA4—nicotine dependence	0.00136	0.00489	CbGpPWpGaD
Diclofenac—CXCR1—GPCR downstream signaling—FGD1—nicotine dependence	0.00136	0.00487	CbGpPWpGaD
Diclofenac—UGT1A1—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00135	0.00486	CbGpPWpGaD
Diclofenac—Asthenia—Varenicline—nicotine dependence	0.00133	0.00242	CcSEcCtD
Diclofenac—Pruritus—Varenicline—nicotine dependence	0.00131	0.00239	CcSEcCtD
Diclofenac—PTGS1—brain—nicotine dependence	0.00131	0.00767	CbGeAlD
Diclofenac—CXCL8—SIDS Susceptibility Pathways—CHRNB2—nicotine dependence	0.0013	0.00468	CbGpPWpGaD
Diclofenac—CXCR1—GPCR ligand binding—OPRM1—nicotine dependence	0.00129	0.00463	CbGpPWpGaD
Diclofenac—UGT1A1—Biological oxidations—CYP2A7—nicotine dependence	0.00128	0.00458	CbGpPWpGaD
Diclofenac—Diarrhoea—Varenicline—nicotine dependence	0.00127	0.00231	CcSEcCtD
Diclofenac—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00127	0.00456	CbGpPWpGaD
Diclofenac—CYP2C8—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00126	0.00454	CbGpPWpGaD
Diclofenac—UGT1A1—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00126	0.00452	CbGpPWpGaD
Diclofenac—PTGS2—brain—nicotine dependence	0.00125	0.00733	CbGeAlD
Diclofenac—CYP2C9—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00125	0.0045	CbGpPWpGaD
Diclofenac—ABCB1—midbrain—nicotine dependence	0.00124	0.00722	CbGeAlD
Diclofenac—CXCR1—Signaling by GPCR—FGD1—nicotine dependence	0.00123	0.00442	CbGpPWpGaD
Diclofenac—Dizziness—Varenicline—nicotine dependence	0.00123	0.00223	CcSEcCtD
Diclofenac—CXCR1—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.00122	0.0044	CbGpPWpGaD
Diclofenac—CXCL8—SIDS Susceptibility Pathways—CHRNA4—nicotine dependence	0.00118	0.00425	CbGpPWpGaD
Diclofenac—Vomiting—Varenicline—nicotine dependence	0.00118	0.00214	CcSEcCtD
Diclofenac—Rash—Varenicline—nicotine dependence	0.00117	0.00213	CcSEcCtD
Diclofenac—Dermatitis—Varenicline—nicotine dependence	0.00117	0.00212	CcSEcCtD
Diclofenac—Headache—Varenicline—nicotine dependence	0.00116	0.00211	CcSEcCtD
Diclofenac—CXCL8—Peptide ligand-binding receptors—OPRM1—nicotine dependence	0.00114	0.00409	CbGpPWpGaD
Diclofenac—CYP2C19—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00113	0.00406	CbGpPWpGaD
Diclofenac—SLCO1C1—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.00112	0.00403	CbGpPWpGaD
Diclofenac—Nausea—Varenicline—nicotine dependence	0.0011	0.002	CcSEcCtD
Diclofenac—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00108	0.0039	CbGpPWpGaD
Diclofenac—CYP1A2—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00107	0.00385	CbGpPWpGaD
Diclofenac—PTGS1—Biological oxidations—CYP2A7—nicotine dependence	0.00104	0.00374	CbGpPWpGaD
Diclofenac—CYP2C9—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00103	0.0037	CbGpPWpGaD
Diclofenac—CXCL8—G alpha (i) signalling events—OPRM1—nicotine dependence	0.00096	0.00345	CbGpPWpGaD
Diclofenac—CXCR1—GPCR ligand binding—DRD2—nicotine dependence	0.000931	0.00335	CbGpPWpGaD
Diclofenac—CXCR1—Signaling Pathways—TAS2R16—nicotine dependence	0.000926	0.00333	CbGpPWpGaD
Diclofenac—CYP1A2—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.000879	0.00316	CbGpPWpGaD
Diclofenac—CYP2B6—Metapathway biotransformation—AKR1B10—nicotine dependence	0.000842	0.00302	CbGpPWpGaD
Diclofenac—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.000837	0.00301	CbGpPWpGaD
Diclofenac—CYP3A4—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.000826	0.00297	CbGpPWpGaD
Diclofenac—CYP2E1—Metapathway biotransformation—AKR1B10—nicotine dependence	0.000824	0.00296	CbGpPWpGaD
Diclofenac—CYP2B6—Biological oxidations—CYP2A7—nicotine dependence	0.000793	0.00285	CbGpPWpGaD
Diclofenac—CYP2B6—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000782	0.00281	CbGpPWpGaD
Diclofenac—CXCL8—GPCR downstream signaling—TAS2R16—nicotine dependence	0.000779	0.0028	CbGpPWpGaD
Diclofenac—CYP1A1—Metapathway biotransformation—AKR1B10—nicotine dependence	0.000777	0.00279	CbGpPWpGaD
Diclofenac—CYP2E1—Biological oxidations—CYP2A7—nicotine dependence	0.000777	0.00279	CbGpPWpGaD
Diclofenac—ABCB1—brain—nicotine dependence	0.000776	0.00454	CbGeAlD
Diclofenac—CYP2E1—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000766	0.00275	CbGpPWpGaD
Diclofenac—CXCL8—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.000763	0.00274	CbGpPWpGaD
Diclofenac—SLC22A11—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.000737	0.00265	CbGpPWpGaD
Diclofenac—CYP1A1—Biological oxidations—CYP2A7—nicotine dependence	0.000732	0.00263	CbGpPWpGaD
Diclofenac—CXCR1—GPCR downstream signaling—OPRM1—nicotine dependence	0.000728	0.00262	CbGpPWpGaD
Diclofenac—CXCR1—Signaling Pathways—FGD1—nicotine dependence	0.000727	0.00261	CbGpPWpGaD
Diclofenac—CYP1A1—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000722	0.0026	CbGpPWpGaD
Diclofenac—CYP2C8—Metapathway biotransformation—AKR1B10—nicotine dependence	0.000712	0.00256	CbGpPWpGaD
Diclofenac—CXCL8—Signaling by GPCR—TAS2R16—nicotine dependence	0.000708	0.00254	CbGpPWpGaD
Diclofenac—CXCL8—G alpha (i) signalling events—DRD2—nicotine dependence	0.000694	0.0025	CbGpPWpGaD
Diclofenac—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.000679	0.00244	CbGpPWpGaD
Diclofenac—CYP2C8—Biological oxidations—CYP2A7—nicotine dependence	0.000672	0.00241	CbGpPWpGaD
Diclofenac—CYP2C8—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000662	0.00238	CbGpPWpGaD
Diclofenac—CXCR1—Signaling by GPCR—OPRM1—nicotine dependence	0.000661	0.00238	CbGpPWpGaD
Diclofenac—CXCR1—Signaling Pathways—AKR1B10—nicotine dependence	0.000642	0.00231	CbGpPWpGaD
Diclofenac—CYP2C19—Metapathway biotransformation—AKR1B10—nicotine dependence	0.000636	0.00229	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—TAS2R16—nicotine dependence	0.000623	0.00224	CbGpPWpGaD
Diclofenac—TTR—Disease—AKR1B10—nicotine dependence	0.000617	0.00222	CbGpPWpGaD
Diclofenac—CXCL8—GPCR downstream signaling—FGD1—nicotine dependence	0.000612	0.0022	CbGpPWpGaD
Diclofenac—CYP2C19—Biological oxidations—CYP2A7—nicotine dependence	0.000599	0.00215	CbGpPWpGaD
Diclofenac—CYP2C19—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000591	0.00213	CbGpPWpGaD
Diclofenac—CXCL8—GPCR ligand binding—OPRM1—nicotine dependence	0.000581	0.00209	CbGpPWpGaD
Diclofenac—CYP2C9—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00058	0.00208	CbGpPWpGaD
Diclofenac—SLC22A8—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.000562	0.00202	CbGpPWpGaD
Diclofenac—PLA2G2A—Metabolism—CYP2A7—nicotine dependence	0.000559	0.00201	CbGpPWpGaD
Diclofenac—CXCL8—Signaling by GPCR—FGD1—nicotine dependence	0.000555	0.002	CbGpPWpGaD
Diclofenac—CXCL8—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000552	0.00198	CbGpPWpGaD
Diclofenac—CYP2C9—Biological oxidations—CYP2A7—nicotine dependence	0.000547	0.00196	CbGpPWpGaD
Diclofenac—CYP2C9—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000539	0.00194	CbGpPWpGaD
Diclofenac—ABCC4—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.000539	0.00194	CbGpPWpGaD
Diclofenac—CXCR1—GPCR downstream signaling—DRD2—nicotine dependence	0.000526	0.00189	CbGpPWpGaD
Diclofenac—CYP1A2—Metapathway biotransformation—AKR1B10—nicotine dependence	0.000495	0.00178	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—FGD1—nicotine dependence	0.000489	0.00176	CbGpPWpGaD
Diclofenac—CXCR1—Signaling by GPCR—DRD2—nicotine dependence	0.000478	0.00172	CbGpPWpGaD
Diclofenac—SLC22A6—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.000469	0.00169	CbGpPWpGaD
Diclofenac—CYP1A2—Biological oxidations—CYP2A7—nicotine dependence	0.000467	0.00168	CbGpPWpGaD
Diclofenac—CYP1A2—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000461	0.00166	CbGpPWpGaD
Diclofenac—CXCR1—Signaling Pathways—WASF2—nicotine dependence	0.000452	0.00163	CbGpPWpGaD
Diclofenac—ABCC1—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.000449	0.00161	CbGpPWpGaD
Diclofenac—CXCR1—Signaling Pathways—WASF1—nicotine dependence	0.000434	0.00156	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—AKR1B10—nicotine dependence	0.000432	0.00155	CbGpPWpGaD
Diclofenac—CXCL8—GPCR ligand binding—DRD2—nicotine dependence	0.00042	0.00151	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—TAS2R16—nicotine dependence	0.000418	0.0015	CbGpPWpGaD
Diclofenac—ALOX5—Metabolism—CYP2A7—nicotine dependence	0.00041	0.00147	CbGpPWpGaD
Diclofenac—CXCR1—Signaling Pathways—OPRM1—nicotine dependence	0.000391	0.0014	CbGpPWpGaD
Diclofenac—CYP3A4—Metapathway biotransformation—AKR1B10—nicotine dependence	0.000382	0.00137	CbGpPWpGaD
Diclofenac—CYP3A4—Biological oxidations—CYP2A7—nicotine dependence	0.00036	0.0013	CbGpPWpGaD
Diclofenac—CYP3A4—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000355	0.00128	CbGpPWpGaD
Diclofenac—CXCL8—GPCR downstream signaling—OPRM1—nicotine dependence	0.000329	0.00118	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—FGD1—nicotine dependence	0.000328	0.00118	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—WASF2—nicotine dependence	0.000304	0.00109	CbGpPWpGaD
Diclofenac—CXCL8—Signaling by GPCR—OPRM1—nicotine dependence	0.000298	0.00107	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—WASF1—nicotine dependence	0.000292	0.00105	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—AKR1B10—nicotine dependence	0.00029	0.00104	CbGpPWpGaD
Diclofenac—CXCR1—Signaling Pathways—DRD2—nicotine dependence	0.000282	0.00101	CbGpPWpGaD
Diclofenac—CYP2C18—Metabolism—CYP2A7—nicotine dependence	0.000276	0.000992	CbGpPWpGaD
Diclofenac—ABCC1—Disease—AKR1B10—nicotine dependence	0.00027	0.000971	CbGpPWpGaD
Diclofenac—UGT2B7—Metabolism—CYP2A7—nicotine dependence	0.000268	0.000965	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—OPRM1—nicotine dependence	0.000263	0.000945	CbGpPWpGaD
Diclofenac—ALB—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.000244	0.000876	CbGpPWpGaD
Diclofenac—CXCL8—GPCR downstream signaling—DRD2—nicotine dependence	0.000238	0.000854	CbGpPWpGaD
Diclofenac—UGT1A1—Metabolism—CYP2A7—nicotine dependence	0.000218	0.000784	CbGpPWpGaD
Diclofenac—CXCL8—Signaling by GPCR—DRD2—nicotine dependence	0.000216	0.000775	CbGpPWpGaD
Diclofenac—ABCB1—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.000214	0.000768	CbGpPWpGaD
Diclofenac—ABCC1—Metabolism—CYP2A7—nicotine dependence	0.00021	0.000756	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—WASF2—nicotine dependence	0.000204	0.000734	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—WASF1—nicotine dependence	0.000196	0.000704	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—DRD2—nicotine dependence	0.00019	0.000683	CbGpPWpGaD
Diclofenac—PTGS2—Disease—AKR1B10—nicotine dependence	0.000181	0.000652	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism—CYP2A7—nicotine dependence	0.000178	0.000639	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—OPRM1—nicotine dependence	0.000176	0.000634	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism—CYP2A7—nicotine dependence	0.000141	0.000507	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—CYP2A7—nicotine dependence	0.000136	0.000488	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—CYP2A7—nicotine dependence	0.000133	0.000478	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—DRD2—nicotine dependence	0.000127	0.000458	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—CYP2A7—nicotine dependence	0.000125	0.00045	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—CYP2A7—nicotine dependence	0.000115	0.000413	CbGpPWpGaD
Diclofenac—ALB—Metabolism—CYP2A7—nicotine dependence	0.000114	0.00041	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—CYP2A7—nicotine dependence	0.000103	0.000368	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—CYP2A7—nicotine dependence	0.0001	0.00036	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—CYP2A7—nicotine dependence	9.35e-05	0.000336	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—CYP2A7—nicotine dependence	7.99e-05	0.000287	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—CYP2A7—nicotine dependence	6.16e-05	0.000222	CbGpPWpGaD
